ACK
PPH icon

Andrew C. Karlinski’s VanEck Pharmaceutical ETF PPH Stock Holding History

Andrew C. Karlinski’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-866
Closed -$58K – 176
2022
Q3 		$58K Hold
866
– – 0.09% 79
2022
Q2 		$67K Hold
866
– – 0.1% 73
2022
Q1 		$69K Buy
+866
New +$66.3K 0.13% 70

Other funds holding PPH

PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
VAS
Valicenti Advisory Services Elmira, New York $530M AUM 46.5% 1-Year Est. Return

Andrew C. Karlinski's PPH Position: Q4 2022 in Review

Andrew C. Karlinski sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2022, closing a stake of 866 shares — an estimated $58K sold.

Andrew C. Karlinski first reported a position in PPH in Q1 2022 and held it in 3 quarters. The position peaked at $69K in Q1 2022. 114 funds tracked by Wall St. Rank hold PPH as of Q4 2022.

  • Andrew C. Karlinski reported no remaining VanEck Pharmaceutical ETF position as of Q4 2022 after selling out during the quarter.
  • Andrew C. Karlinski sold 866 VanEck Pharmaceutical ETF shares in Q4 2022, an estimated $58K.
  • Andrew C. Karlinski first reported a position in VanEck Pharmaceutical ETF in Q1 2022 and held it in 3 quarters.
  • Andrew C. Karlinski's VanEck Pharmaceutical ETF position peaked at $69K in Q1 2022.
  • 114 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2022.

Based on Andrew C. Karlinski's 13F filing for Q4 2022.